Group One Trading, L.P. Aeterna Zentaris Inc. Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.17 - $0.37 $17 - $37	-100 Reduced 0.04%	222,144 $44,000
Q1 2022 May 12, 2022	BUY	$0.33 - $0.42 $9,881 - $12,576	29,943 Added 15.57%	222,244 $81,000
Q4 2021 Feb 11, 2022	BUY	$0.36 - $0.77 $47,298 - $101,166	131,385 Added 215.68%	192,301 $68,000
Q3 2021 Nov 12, 2021	SELL	$0.59 - $0.88 $36,760 - $54,829	-62,306 Reduced 50.56%	60,916 $46,000
Q2 2021 Aug 10, 2021	BUY	$0.83 - $1.14 $102,274 - $140,473	123,222 New	123,222 $108,000
Q2 2020 Aug 13, 2020	SELL	$0.45 - $1.2 $201 - $536	-447 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$0.77 - $1.08 $486 - $682	-632 Reduced 58.57%	447 $0
Q3 2019 Nov 12, 2019	BUY	$1.0 - $2.97 $1,079 - $3,204	1,079 New	1,079 $1,000
Q4 2017 Feb 09, 2018	SELL	$1.87 - $2.7 $27,432 - $39,609	-14,670 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.81 - $2.23 $26,552 - $32,714	14,670	14,670 $30,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.